|Monday, 16 April 2018, 13:23 HKT/SGT|
Source: Fujitsu Ltd
|More than doubles the accuracy of structure detection in medical images|
TOKYO, Apr 16, 2018 - (JCN Newswire) - Fujitsu Laboratories Ltd. today announced the development of AI technology that uses deep learning to detect objects(1), even in cases when only a small amount of data is available for learning.
In recent years, there have been efforts to automate tasks in a variety of fields. In the medical field, for example, there has been a desire to use AI to automate such tasks as detecting objects, including anomalous spots, in the analysis of diagnostic images. It is typical to utilize deep learning in object detection, which involves identifying specific structures in a diagnostic image, but in order to produce accurate results, tens of thousands of images with correct data are necessary. However, since correct data can only be created by doctors with expert knowledge, it has been difficult to obtain the images in such huge volumes.
Now, Fujitsu Laboratories has developed a technology (patent pending) that takes the object location estimates produced by the object detection neural network and makes them into a reconstruction of the original image. Then, by assessing the difference between the original input image and the reconstructed image, it can create large volumes of correct data where the position of objects has been accurately estimated. This raises the level of accuracy in object detection. Fujitsu Laboratories has collaborated with the Graduate School of Medicine at Kyoto University and applied the newly developed technology to the detection of bodies called glomeruli (singular glomerulus) in kidney biopsy images. The results of an evaluation showed that in an experiment using 50 images with correct data and 450 images without correct data, compared with existing training methods using only the same number of images with correct data, the accuracy of the new technology had more than doubled, under the stipulation of an oversight rate of less than 10%.
Expectations have been increasing for the automation of tasks using AI in a variety of fields in recent years. Fujitsu Laboratories has been conducting a joint research with the Graduate School of Medicine at Kyoto University(2), and one of those initiatives has been research into supporting the diagnosis of kidney disease using AI. In the medical field, there is a diagnostic test that checks the number and status of structures called glomeruli, which handle the filtration of blood. The test uses images taken in a microscope of a slice of a kidney extracted in a procedure called a kidney biopsy. It is widely known, however, that there are large variations in the time required for the task of finding glomeruli while the image is enlarged, and in how the observer evaluates the condition of the bodies, even among experts. This has created a demand for an accurate, automated count of the number of glomeruli and diagnosis.
To automatically extract data for possible glomeruli from images, it is necessary to identify the locations of the glomeruli from the images provided, and deep learning is widely known as a method for identifying the locations and types of objects in images. For this training method, it is essential to have large volumes of images along with information on the locations and types of objects in the images (correct data). However, it has previously been difficult to prepare large volumes of correct data, because it must be created by doctors with specialized knowledge.
About the Newly Developed Technology
Now, Fujitsu Laboratories has developed a partially trained object detection technology that is capable of training a deep neural network to identify objects using a large volume of images without correct data and a small volume of images with correct data.
In order to increase images with correct data, one might consider a method that increases the amount of images in the face of large volumes of image data, by having the neural network estimate object locations and supplementing them as correct data. Neural networks that have been trained on small amounts of correct data, however, have a problem unique to object detection, in that they face difficulty in estimating the location of an object in precisely the same place as it is in reality. Therefore, if the data from this imprecise estimation is used to further train the model, accuracy will be undermined.
In response, Fujitsu Laboratories has now developed technology to evaluate the degree to which the output location estimate is correct, by using the estimated results of the detection neural network as a key to reconstruct the original image using a neural network for reconstruction. Because images reconstructed from incorrect location estimates will not match the original image, by comparing the two images, it is possible to evaluate the accuracy of an estimate location. By repeatedly conducting estimations and reconstructions on large volumes of images in this way, Fujitsu Laboratories has made it possible to increase the amount of correct data while also gradually approaching a state in which the model produces correct location estimates, thereby increasing accuracy.
In joint research with the Graduate School of Medicine at Kyoto University, this technology was applied to the detection of glomeruli in kidney biopsy images. The research compared an existing object detection neural network trained using only 50 images with the correct data, with this technology, trained using those same images and an additional 450 images without the correct data. The results showed that, stipulating an oversight rate of less than 10%, similar to that of human evaluators, this technology achieved an accuracy of 27%, more than double that of the existing technology. This means that, where a single image might have an average of 22 glomeruli, this technology reduced the candidate locations needed to be searched due to the above stated oversight rate to 77, reducing post-processing costs. By increasing the accuracy of glomerulus detection and reducing the number of candidate locations, it is expected to accelerate the research of kidney diseases and the development of the diagnosis system based on glomeruli detection.
Though its joint research with the Graduate School of Medicine at Kyoto University, Fujitsu will endeavor to realize the quantitative evaluation method of kidney by applying the new detection technology of glomeruli. This technology is not only applicable to specific applications such as kidney biopsy images, but also to object detection more broadly, in fields lacking in images with the correct data. For example, the company envisions the technology to be applied to a broad range of areas beyond healthcare, such as in detecting defective products using images from production lines, identifying anomalous locations from diagnostic images using a variety of sensors in infrastructure facilities, and creating lists of materials to be used from architectural blueprints. Fujitsu Laboratories aims to deploy this technology during fiscal 2018 as a learning model construction technology supporting Fujitsu's Zinrai Platform Service, which makes AI technology available through APIs.
(1) Deep Learning
One of the major artificial intelligence (AI) technologies. Fujitsu has applied for approximately 140 patents related to deep learning, both inside and outside Japan.
(2) Joint research with the Gradual School of Medicine at Kyoto University
"Kyoto University and Fujitsu Launch Joint Research Project to Advance Medicine through the Use of AI,"
About Fujitsu Laboratories
Founded in 1968 as a wholly owned subsidiary of Fujitsu Limited, Fujitsu Laboratories Ltd. is one of the premier research centers in the world. With a global network of laboratories in Japan, China, the United States and Europe, the organization conducts a wide range of basic and applied research in the areas of Next-generation Services, Computer Servers, Networks, Electronic Devices and Advanced Materials. For more information, please see: http://www.fujitsu.com/jp/group/labs/en/.
About Fujitsu Ltd
Fujitsu is the leading Japanese information and communication technology (ICT) company, offering a full range of technology products, solutions, and services. Approximately 140,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE: 6702) reported consolidated revenues of 4.1 trillion yen (US $39 billion) for the fiscal year ended March 31, 2018.
For more information, please see www.fujitsu.com.
This release at www.fujitsu.com/global/about/resources/news/press-releases/.
Fujitsu Laboratories Ltd.
Artificial Intelligence Laboratory
Public and Investor Relations
Apr 16, 2018 13:23 HKT/SGT
Source: Fujitsu Ltd
Fujitsu Ltd (TSE: 6702)
Topic: Press release summary
Sectors: Electronics, Enterprise IT, BioTech
From the Asia Corporate News Network
Copyright © 2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|Mar 13, 2019 18:38 HKT/SGT|
Fujitsu Formulates "Fujitsu Group AI Commitment," Demonstrating Dedication to Safe and Secure Use of AI|
|Mar 11, 2019 10:31 HKT/SGT|
Fujitsu Completes Image Processing Field Trial to Support Restoration of Earthquake-Damaged Kumamoto Castle|
|Mar 11, 2019 10:07 HKT/SGT|
Yamaha Motor and Fujitsu Begin IoT-based Field Trial to Improve Sailing Performance for 470 Class Events|
|Mar 4, 2019 10:05 HKT/SGT|
Fujitsu Offers Online Biometric Authentication Service for TEPCO Systems|
|Mar 1, 2019 12:58 HKT/SGT|
Fujitsu Limited Announces Recruitment Plans|
|Mar 1, 2019 11:55 HKT/SGT|
Fujitsu Successfully Develops Technology to Miniaturize High-Sensitivity Infrared Cameras for Autonomous Ship Navigation|
|Feb 27, 2019 09:13 HKT/SGT|
Fujitsu and Sony Global Education Initiate Blockchain Field Trials for Course Records and Transcript Management|
|Feb 18, 2019 10:24 HKT/SGT|
Fujitsu Receives Order for Massively Parallel Supercomputer System from The University of Tokyo|
|Feb 13, 2019 17:01 HKT/SGT|
Fujitsu Launches "Healthcare Personal service Platform" to Manage Health and Medical Information|
|Feb 12, 2019 10:50 HKT/SGT|
Sapporo Medical University and Fujitsu in Joint R&D for Diabetes Treatment that Uses AI-based Machine Learning|
|More news >>|